Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
Uro-Oncology
Related content
Uro-Oncology
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis
Eur Urol.
Sathianathen NJ, Koschel S, Thangasamy IA, Teh J, Alghazo O, Butcher G, Howard H, Kapoor J, Lawrentschuk N, Siva S, Azad A, Tran B, Bolton D, Murphy DG
doi: 10.1016/j.eururo.2019.09.004.
COMMENTED
Uro-Oncology
New Anti-Androgen Compounds Compared to Docetaxel in Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis
★ 2
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
J Urol.
Marchioni M, Di Nicola M, Primiceri G, Novara G, Castellan P, Paul A, Veccia A, Autorino R, Cindolo L, Schips L
doi: 10.1097/JU.0000000000000636.
Uro-Oncology
Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis
JAMA Oncol.
Foerster B, Pozo C, Abufaraj M, Mari A, Kimura S, D'Andrea D, John H, Shariat SF
doi: 10.1001/
Further Publications UrologyFurther Publications Gynecology
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
Lancet.
Vale CL, Fisher D, Kneebone A, Parker C, Pearse M, Richaud P, Sargos P, Sydes MR, Brawley C, Brihoum M, Brown C, Chabaud S, Cook A, Forcat S, Fraser-Browne C, Latorzeff I, Parmar MKB, Tierney JF, ARTISTIC Meta-analysis Group.
doi: 10.1016/S0140-6736(20)31952-8.
Uro-Oncology
Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis
Prostate Cancer Prostatic Dis.
Sun D, Cao M, Li H, Ren J, Shi J, Li N, Chen W
doi: 10.1038/s41391-020-00268-2.
Uro-Oncology
Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis
Prostate Cancer Prostatic Dis.
Cui H, Wang Y, Li F, He G, Jiang Z, Gang X, Wang G
doi: 10.1038/s41391-020-00267-3.
Uro-Oncology
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate Cancer Prostatic Dis
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI
doi: 10.1038/s41391-021-00395-4
Uro-Oncology
Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis
Prostate Cancer Prostatic Dis
Lopez P, Newton RU, Taaffe DR, Singh F, Buffart LM, Spry N, Tang C, Saad F, Galvão DA
doi: 10.1038/s41391-021-00442-0
Uro-Oncology
The association between occupational asbestos exposure with the risk of incidence and mortality from prostate cancer: a systematic review and meta-analysis
Prostate Cancer Prostatic Dis
Godono A, Clari M, Franco N, Ciocan C, Mansour I, Zunarelli C, Pira E, Boffetta P
doi: 10.1038/s41391-021-00437-x